Biomarkers for isolated congenital heart disease based on maternal amniotic fluid metabolomics analysis

Biomarkers for isolated congenital heart disease based on maternal amniotic fluid metabolomics analysis

Abstract Introduction Congenital heart disease (CHD) is one of the most prevalent birth defects in the world. The pathogenesis of CHD is complex and unclear. With the development of metabolomics technology, variations in metabolites may provide new clues about the causes of CHD and may serve as a bi...

Full description

Bibliographic Details
Main Authors: Xuelian Yuan, Lu Li, Hong Kang, Meixian Wang, Jing Zeng, Yanfang Lei, Nana Li, Ping Yu, Xiaohong Li, Zhen Liu
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Cardiovascular Disorders
Subjects:
Congenital heart disease
Metabolomics
Reproduction
Biomarker
Diagnosis
Online Access:https://doi.org/10.1186/s12872-022-02912-2

Similar Items

Similar Items